Company profile for Vedanta Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The human body is an ecosystem. Trillions of microbes call us home. They form the human microbiome, which performs critical functions that preserve our health including modulating our immune system and providing colonization resistance against infectious pathogens. Alterations of the human microbiome are increasingly recognized as a key factor in development of immune and infectious diseases. We rationally design medicines bas...
The human body is an ecosystem. Trillions of microbes call us home. They form the human microbiome, which performs critical functions that preserve our health including modulating our immune system and providing colonization resistance against infectious pathogens. Alterations of the human microbiome are increasingly recognized as a key factor in development of immune and infectious diseases. We rationally design medicines based on consortia of human commensal bacteria to treat disease, using insights from microbial ecology, mucosal immunology, and human interventional studies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
19 Blackstone Street Cambridge, MA 02139
Telephone
Telephone
857-706-1427
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.biospace.com/business/vedanta-downsizes-by-20-after-phase-ii-stumble-in-ulcerative-colitis

BIOSPACE
14 Aug 2025

https://www.fiercebiotech.com/biotech/vedantas-live-bacteria-cocktail-fails-reduce-ulcerative-colitis-severity-phase-2-trial

FIERCE BIOTECH
13 Aug 2025

https://www.businesswire.com/news/home/20250126745982/en

BUSINESSWIRE
27 Jan 2025

https://pharmatimes.com/news/vedanta-biosciences-reveals-phase-2-ve303-results/

PHARMATIMES
27 Jan 2025

https://www.businesswire.com/news/home/20250123611854/en

BUSINESSWIRE
23 Jan 2025

https://www.businesswire.com/news/home/20241016537619/en

BUSINESSWIRE
16 Oct 2024

ABOUT THIS PAGE

Contact Vedanta Biosciences and get a quotation

Vedanta Biosciences is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of VE416 bulk offered by Vedanta Biosciences

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty